Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 16Recruiting 7Terminated 6Active not recruiting 5Unknown 4Not yet recruiting 3

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Lung Neoplasms 4Anus Neoplasms 3Peritoneal Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Carcinoma, Hepatocellular 2Appendiceal Neoplasms 2Stomach Neoplasms 1Recurrence Hepatocellular Carcinoma 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms 1Mesothelioma 1Liver Metastasis 1Hyperthermia 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma 1Breast Neoplasms 1Anus Diseases 1

Interventions

Gemcitabine 7Cystectomy 5Cisplatin 5durvalumab 4Neoadjuvant Therapy 4Mitomycin 4atezolizumab 3Transurethral Resection of Bladder 3Nivolumab 3Epirubicin 3Chemoradiotherapy 3BCG Vaccine 3Anesthesia, Spinal 3tislelizumab 2disitamab vedotin 2catumaxomab 2Vitamin E 2Urinary Diversion 2Sunitinib 2Selenium 2Robotic Surgical Procedures 2Multiparametric Magnetic Resonance Imaging 2Magnetic Resonance Imaging 2Immunohistochemistry 2Fentanyl 2Docetaxel 2Diathermy 2Cystoscopy 2Chemoprevention 2BCG Connaught 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Urinary Bladder Neoplasms × Mitomycin × Clear all
NCT02948543 2023-06-18

BCG+MM

University of Sydney

Phase 3 Unknown
501 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02070120 2020-03-19

CALIBER

Institute of Cancer Research, United Kingdom

Phase 2 Unknown
82 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03790384 2018-12-31

MITOBCG

Azienda Ospedaliera "Sant'Andrea"

Phase 4 Unknown
140 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT01094964 2013-08-12

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
242 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡